Observational studyAmerican journal of hematology2026

Real-World Efficacy and Safety of Glofitamab-Based Salvage Therapy in Chinese Patients With Relapsed or Refractory Aggressive B-Cell Lymphomas.

Jin Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.